Literature DB >> 31345345

Identification of a Novel Icotinib-Sensitive EGFR-SEPTIN14 Fusion Variant in Lung Adenocarcinoma by Next-Generation Sequencing.

You-Cai Zhu1, Wen-Xian Wang2, Xing-Liang Li3, Chun-Wei Xu4, Gang Chen5, Wu Zhuang6, Tangfeng Lv7, Yong Song7.   

Abstract

Entities:  

Year:  2019        PMID： 31345345     DOI： 10.1016/j.jtho.2019.03.031

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  3 in total

1.  Emerging a Novel VOPP1-EGFR Fusion Coexistent With T790M as an Acquired Resistance Mechanism to Prior Icotinib and Sensitive to Osimertinib in a Patient With EGFR L858R Lung Adenocarcinoma: A Case Report.

Authors:  Xia Wang; Weiwei Peng; Zhimin Zeng; Jing Cai; Anwen Liu
Journal:  Front Oncol       Date:  2021-12-22       Impact factor: 6.244

2.  Profiling of gene fusion involving targetable genes in Chinese gastric cancer.

Authors:  Zhen-Hua Liu; Bo-Wen Zhu; Min Shi; Yu-Rong Qu; Xun-Jun He; Hong-Ling Yuan; Jie Ma; Wei Li; Dan-Dan Zhao; Zheng-Chuang Liu; Bao-Ming Wang; Chun-Yang Wang; Hou-Quan Tao; Tong-Hui Ma
Journal:  World J Gastrointest Oncol       Date:  2022-08-15

3.  Gefitinib Combined with Cetuximab for the Treatment of Lung Adenocarcinoma Harboring the EGFR-Intergenic Region (SEC61G) Fusion and EGFR Amplification.

Authors:  Guoqing Zhang; Peiyi Xia; Shanshan Zhao; Lulu Yuan; Xiaosu Wang; Xiangnan Li; Jindong Li
Journal:  Oncologist       Date:  2021-08-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.